HIGHLIGHTS
- who: Bart Meuris from the devices implanted and the possibility to collect data on interaction of multiple valve treatmentsThe main objective of the aortic and mitral/tricuspid substudies is to monitor the ongoing safety and device performance of the commercially available Corcym products and accessories used for the treatment of aortic and mitral/tricuspid valve disease in a real-world setting, based on standard-of-care data collection. The third substudy focuses on the MEMO D device, an advanced technological evolution within the mitral portfolio. This substudy takes advantage of a dedicated echocardiographic CoreLab (Department of Medicine . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.